Raia Drogasil (OTCMKTS:RADLY) Sees Strong Trading Volume – Still a Buy?

Shares of Raia Drogasil S.A. (OTCMKTS:RADLY) saw unusually-high trading volume on Friday. Approximately 272,606 shares changed hands during mid-day trading, an increase of 212% from the previous session’s volume of 87,507 shares. The stock last traded at $4.15 and had previously closed at $4.15.

Raia Drogasil Trading Up 0.6%

The stock has a market cap of $5.47 billion and a PE ratio of 83.20. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99. The firm has a fifty day simple moving average of $3.71 and a two-hundred day simple moving average of $3.88.

Raia Drogasil (OTCMKTS:RADLY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. Raia Drogasil had a net margin of 2.97% and a return on equity of 18.20%. The company had revenue of $2.17 billion for the quarter, compared to analysts’ expectations of $2.32 billion. As a group, equities analysts expect that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.

About Raia Drogasil

Raia Drogasil SA, known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise.

The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products.